Franceinfo Health Update: May 9, 2026
Recent clinical evaluations confirm that GLP-1 receptor agonists, originally designed for type 2 diabetes and obesity, significantly reduce the apnea-hypopnea index (AHI) in adults with obstructive sleep apnea (OSA). This ... Read More